MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 168 filers reported holding MERIDIAN BIOSCIENCE INC in Q1 2020. The put-call ratio across all filers is 1.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,596,000 | -44.1% | 163,346 | -45.7% | 0.04% | -36.2% |
| Q3 2019 | $2,853,000 | -11.0% | 300,670 | +11.5% | 0.07% | 0.0% |
| Q2 2019 | $3,205,000 | +2.9% | 269,768 | +52.5% | 0.07% | +1.5% |
| Q1 2019 | $3,115,000 | +7.5% | 176,868 | +5.9% | 0.07% | -9.3% |
| Q4 2018 | $2,898,000 | -5.9% | 166,937 | -19.5% | 0.08% | +17.2% |
| Q3 2018 | $3,079,000 | +12.9% | 207,307 | +21.3% | 0.06% | +23.1% |
| Q2 2018 | $2,726,000 | +34.5% | 170,904 | +19.7% | 0.05% | +20.9% |
| Q1 2018 | $2,027,000 | +25.4% | 142,779 | +25.0% | 0.04% | +22.9% |
| Q4 2017 | $1,616,000 | -28.0% | 114,222 | -27.7% | 0.04% | -18.6% |
| Q3 2017 | $2,245,000 | +7.5% | 158,085 | +19.2% | 0.04% | +2.4% |
| Q2 2017 | $2,089,000 | +95.2% | 132,656 | +71.1% | 0.04% | +61.5% |
| Q1 2017 | $1,070,000 | – | 77,546 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |